Skip to content

New patient pricing is live · From $149/mo, flat at every dose · Free to start

Longevity

Longevity Peptides: A Grounded Guide to the Research

MOTS-c, epithalon, SS-31, NAD+ and more — the longevity peptide space is fast-growing and heavy on hype. Here is a grounded look at what the research supports.

By Toned Team · Reviewed by the Toned editorial team

Published May 6, 2026 · Last reviewed July 7, 2026 · 2 min read

Longevity peptides are compounds studied for aging-related pathways — mitochondrial function, cellular stress response, and metabolism. The category is growing fast and is heavy on hype, so this guide does the opposite of the marketing: it maps what is actually being researched, and it keeps the framing honest. For nearly all of these, human evidence is early and limited.

What is MOTS-c studied for?

MOTS-c is a mitochondrial-derived peptide studied for its role in metabolic regulation and exercise-related signaling. The foundational research is compelling at the mechanistic level — it appears to influence how cells handle energy and stress — but it sits largely in the preclinical stage. Interesting biology; not a proven human intervention.

What does the research on epithalon show?

Epithalon (epitalon) is a synthetic peptide studied in aging models, including work examining lifespan and telomere-related endpoints in animals. It is one of the more cited longevity peptides, and also one where the gap between animal findings and rigorous human evidence is widest. Read it as studied for aging pathways, not established for human longevity.

How is SS-31 different from the others?

SS-31 (elamipretide) targets cardiolipin in the mitochondrial membrane and has been investigated as a mitochondrial-protective compound, including in some clinical research for specific conditions. Of the peptides here it has among the more developed research programs, though that work is disease-specific rather than a general anti-aging claim.

Where do NAD+ and related molecules fit?

NAD+ is not a peptide, but it is central to this conversation because NAD-boosting molecules are among the most-studied metabolic-aging interventions, with a real and growing research base. GHK-Cu, covered in our copper peptide guide, overlaps with the longevity interest in tissue and skin aging. Toned does not currently offer NAD+ or GHK-Cu; both are covered here for education only.

The honest bottom line

The longevity peptide space is where genuine science, early evidence, and heavy marketing all sit on top of each other. MOTS-c, epithalon, and SS-31 are worth understanding and are studied for real pathways — but the human data is thin, several are not FDA-approved, and none of them should be self-sourced. If this interests you, the responsible path is a licensed provider who can separate the evidence from the hype. Start with the peptide glossary to get the vocabulary straight; what Toned prescribes today is compounded GLP-1 medication.

References

  1. Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metab. 2015. PubMed
  2. Anisimov VN, Khavinson VKh et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003. PubMed
  3. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics (SS-31). Br J Pharmacol. 2014. PubMed
  4. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules. Cell Metab. 2018. PubMed

This article is for general education and is not medical advice. Talk to a licensed provider about your individual situation.

FAQ

Questions this article answers.

More questions answered in the full FAQ.

Your future self says hi.

Five minutes online today. A licensed provider handles the rest — and you never sit in a waiting room.

Get started — it's free

Takes ~5 min · 100% online · No insurance needed